Tapewire

Nasdaq · USD

GH

Guardant Health, Inc.

Export transactions ↓
Tapewire entity
3238
SEC CIK
0001576280
Parsed reports
867

Last 12 months

Inside the activity.

1 purchase rows · 142 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 2025048
Jan 202606
Feb 202600
Mar 202606
Apr 202602
May 2026024
Jun 2026126
Jul 202601
Aug 2026017
Sep 202608
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 15, 2025 Filed Mar 18, 2025 21:23 UTC
Bell Michael BrianChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 2,039 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000088 · wk-form4_1742333005.xml · derivative · entry 5

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,195

Underlying: Common Stock · 2,039 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 21:23 UTC
Bell Michael BrianChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 1,233 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000088 · wk-form4_1742333005.xml · derivative · entry 4

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,932

Underlying: Common Stock · 1,233 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on May 9, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on March 15, 2023 and the remaining 75% of the shares vest in equal quarterly installments over the remaining three-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 21:23 UTC
Bell Michael BrianChief Financial Officer
Tax withholdingCommon Stock 1,659 $42.89 $71,154.51
Disclosure

SEC source: 0001576280-25-000088 · wk-form4_1742333005.xml · nonDerivative · entry 3

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,361

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 21:23 UTC
Bell Michael BrianChief Financial Officer
Exercise / conversionCommon Stock 2,039 $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000088 · wk-form4_1742333005.xml · nonDerivative · entry 2

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,020

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 21:23 UTC
Bell Michael BrianChief Financial Officer
Exercise / conversionCommon Stock 1,233 $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000088 · wk-form4_1742333005.xml · nonDerivative · entry 1

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,981

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 21:27 UTC
Kalia KumudChief Information Officer
Exercise / conversionRestricted Stock Units · Derivative 637 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000094 · wk-form4_1742333269.xml · derivative · entry 4

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,187

Underlying: Common Stock · 637 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 21:27 UTC
Kalia KumudChief Information Officer
Tax withholdingCommon Stock 228 $42.89 $9,778.92
Disclosure

SEC source: 0001576280-25-000094 · wk-form4_1742333269.xml · nonDerivative · entry 2

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,220

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 21:27 UTC
Kalia KumudChief Information Officer
Exercise / conversionCommon Stock 637 $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000094 · wk-form4_1742333269.xml · nonDerivative · entry 1

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,448

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:21 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
Exercise / conversionPerformance-Based Restricted Stock Units · Derivative 68,769 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000086 · wk-form4_1742332910.xml · derivative · entry 3

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 68,769 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:21 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
Tax withholdingCommon Stock 34,853 $42.89 $1,494,845.17
Disclosure

SEC source: 0001576280-25-000086 · wk-form4_1742332910.xml · nonDerivative · entry 2

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,295,247

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:21 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
Exercise / conversionCommon Stock 68,769 $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000086 · wk-form4_1742332910.xml · nonDerivative · entry 1

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,330,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:20 UTC
Eltoukhy HelmyDirector · Co-Chief Executive Officer
Exercise / conversionPerformance-Based Restricted Stock Units · Derivative 68,769 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000084 · wk-form4_1742332814.xml · derivative · entry 3

Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 68,769 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:20 UTC
Eltoukhy HelmyDirector · Co-Chief Executive Officer
Tax withholdingCommon Stock 34,853 $42.89 $1,494,845.17
Disclosure

SEC source: 0001576280-25-000084 · wk-form4_1742332814.xml · nonDerivative · entry 2

Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,395,081

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:20 UTC
Eltoukhy HelmyDirector · Co-Chief Executive Officer
Exercise / conversionCommon Stock 68,769 $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000084 · wk-form4_1742332814.xml · nonDerivative · entry 1

Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,429,934

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:40 UTC
Freeman ChrisChief Commercial Officer
GrantRestricted Stock Units · Derivative 15,430 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000074 · wk-form4_1741898412.xml · derivative · entry 2

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,430

Underlying: Common Stock · 15,430 shares

Expires not disclosed

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:40 UTC
Freeman ChrisChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 23,145 $0.00 Strike: $43.10 $0.00
Disclosure

SEC source: 0001576280-25-000074 · wk-form4_1741898412.xml · derivative · entry 1

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,145

Underlying: Common Stock · 23,145 shares

Expires 2035-03-12

F1 · derivative.exercise_date: This represents a stock option award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:46 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
GrantRestricted Stock Units · Derivative 116,010 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000082 · wk-form4_1741898778.xml · derivative · entry 2

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,010

Underlying: Common Stock · 116,010 shares

Expires not disclosed

F3 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests with respect to 33% of the shares on January 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:46 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
GrantRestricted Stock Units · Derivative 19,258 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000082 · wk-form4_1741898778.xml · derivative · entry 1

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,258

Underlying: Common Stock · 19,258 shares

Expires not disclosed

F1 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:44 UTC
Saia John G.Chief Legal Officer
GrantRestricted Stock Units · Derivative 17,866 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000080 · wk-form4_1741898689.xml · derivative · entry 2

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,866

Underlying: Common Stock · 17,866 shares

Expires not disclosed

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:44 UTC
Saia John G.Chief Legal Officer
GrantStock Option (Right to Buy) · Derivative 26,799 $0.00 Strike: $43.10 $0.00
Disclosure

SEC source: 0001576280-25-000080 · wk-form4_1741898689.xml · derivative · entry 1

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,799

Underlying: Common Stock · 26,799 shares

Expires 2035-03-12

F1 · derivative.exercise_date: This represents a stock option award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:43 UTC
Monroe Terilyn J.Chief People Officer
GrantRestricted Stock Units · Derivative 16,242 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000078 · wk-form4_1741898591.xml · derivative · entry 2

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,242

Underlying: Common Stock · 16,242 shares

Expires not disclosed

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:43 UTC
Monroe Terilyn J.Chief People Officer
GrantStock Option (Right to Buy) · Derivative 24,363 $0.00 Strike: $43.10 $0.00
Disclosure

SEC source: 0001576280-25-000078 · wk-form4_1741898591.xml · derivative · entry 1

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,363

Underlying: Common Stock · 24,363 shares

Expires 2035-03-12

F1 · derivative.exercise_date: This represents a stock option award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:32 UTC
EAGLE CRAIGChief Medical Officer
GrantRestricted Stock Units · Derivative 16,242 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000070 · wk-form4_1741897930.xml · derivative · entry 2

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,242

Underlying: Common Stock · 16,242 shares

Expires not disclosed

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:32 UTC
EAGLE CRAIGChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 24,363 $0.00 Strike: $43.10 $0.00
Disclosure

SEC source: 0001576280-25-000070 · wk-form4_1741897930.xml · derivative · entry 1

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,363

Underlying: Common Stock · 24,363 shares

Expires 2035-03-12

F1 · derivative.exercise_date: This represents a stock option award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:41 UTC
Kalia KumudChief Information Officer
GrantRestricted Stock Units · Derivative 16,242 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000076 · wk-form4_1741898504.xml · derivative · entry 2

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,242

Underlying: Common Stock · 16,242 shares

Expires not disclosed

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:41 UTC
Kalia KumudChief Information Officer
GrantStock Option (Right to Buy) · Derivative 24,363 $0.00 Strike: $43.10 $0.00
Disclosure

SEC source: 0001576280-25-000076 · wk-form4_1741898504.xml · derivative · entry 1

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,363

Underlying: Common Stock · 24,363 shares

Expires 2035-03-12

F1 · derivative.exercise_date: This represents a stock option award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:34 UTC
Eltoukhy HelmyDirector · Co-Chief Executive Officer
GrantRestricted Stock Units · Derivative 116,010 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000072 · wk-form4_1741898050.xml · derivative · entry 2

Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,010

Underlying: Common Stock · 116,010 shares

Expires not disclosed

F3 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests with respect to 33% of the shares on January 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:34 UTC
Eltoukhy HelmyDirector · Co-Chief Executive Officer
GrantRestricted Stock Units · Derivative 19,258 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000072 · wk-form4_1741898050.xml · derivative · entry 1

Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,258

Underlying: Common Stock · 19,258 shares

Expires not disclosed

F1 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:30 UTC
Chudova DaryaChief Technology Officer
GrantRestricted Stock Units · Derivative 20,302 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000068 · wk-form4_1741897853.xml · derivative · entry 2

Chudova Darya · CIK 0001977179 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,302

Underlying: Common Stock · 20,302 shares

Expires not disclosed

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:30 UTC
Chudova DaryaChief Technology Officer
GrantStock Option (Right to Buy) · Derivative 30,453 $0.00 Strike: $43.10 $0.00
Disclosure

SEC source: 0001576280-25-000068 · wk-form4_1741897853.xml · derivative · entry 1

Chudova Darya · CIK 0001977179 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,453

Underlying: Common Stock · 30,453 shares

Expires 2035-03-12

F1 · derivative.exercise_date: This represents a stock option award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:29 UTC
Bell Michael BrianChief Financial Officer
GrantRestricted Stock Units · Derivative 22,332 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000066 · wk-form4_1741897745.xml · derivative · entry 2

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,332

Underlying: Common Stock · 22,332 shares

Expires not disclosed

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 12, 2025 Filed Mar 13, 2025 20:29 UTC
Bell Michael BrianChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 33,498 $0.00 Strike: $43.10 $0.00
Disclosure

SEC source: 0001576280-25-000066 · wk-form4_1741897745.xml · derivative · entry 1

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,498

Underlying: Common Stock · 33,498 shares

Expires 2035-03-12

F1 · derivative.exercise_date: This represents a stock option award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:48 UTC Exercise / conversionRestricted Stock Units · Derivative 67 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000064 · wk-form4_1741211287.xml · derivative · entry 3

Joyce Meghan V. · CIK 0001770749 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 332

Underlying: Common Stock · 67 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock unit vested as to 25% of the shares subject to the award on August 4, 2022, and the remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of August 4, 2022 during the three-year period thereafter.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:48 UTC Exercise / conversionCommon Stock 67 $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000064 · wk-form4_1741211287.xml · nonDerivative · entry 2

Joyce Meghan V. · CIK 0001770749 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,714

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:48 UTC SaleCommon Stock 100 $42.71 $4,271.00
Disclosure

SEC source: 0001576280-25-000064 · wk-form4_1741211287.xml · nonDerivative · entry 1

Joyce Meghan V. · CIK 0001770749 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,647

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:11 UTC
Freeman ChrisChief Commercial Officer
Exercise / conversionPerformance-Based Restricted Stock Units · Derivative 5,686 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000056 · wk-form4_1741129889.xml · derivative · entry 4

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,376

Underlying: Common Stock · 5,686 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. The remaining 67% of the shares vest over the following two years, with 33% of the shares subject to the award vesting on January 1, 2026, and 34% of the shares subject to the award vesting on January 1, 2027.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:11 UTC
Freeman ChrisChief Commercial Officer
Tax withholdingCommon Stock 1,566 $42.55 $66,633.30
Disclosure

SEC source: 0001576280-25-000056 · wk-form4_1741129889.xml · nonDerivative · entry 2

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,789

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:11 UTC
Freeman ChrisChief Commercial Officer
Exercise / conversionCommon Stock 5,686 $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000056 · wk-form4_1741129889.xml · nonDerivative · entry 1

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,355

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:16 UTC
Saia John G.Chief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 263 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000062 · wk-form4_1741130180.xml · derivative · entry 6

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 527

Underlying: Common Stock · 263 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, and vested as to 25% of the shares subject to such award on September 1, 2022, the remaining 75% of the shares subject to such award vest in equal installments on each quarterly anniversary of September 1, 2022 during the three-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:16 UTC
Saia John G.Chief Legal Officer
Exercise / conversionPerformance-Based Restricted Stock Units · Derivative 5,686 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000062 · wk-form4_1741130180.xml · derivative · entry 5

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,376

Underlying: Common Stock · 5,686 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. The remaining 67% of the shares vest over the following two years, with 33% of the shares subject to the award vesting on January 1, 2026, and 34% of the shares subject to the award vesting on January 1, 2027.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:16 UTC
Saia John G.Chief Legal Officer
Tax withholdingCommon Stock 3,079 $42.55 $131,011.45
Disclosure

SEC source: 0001576280-25-000062 · wk-form4_1741130180.xml · nonDerivative · entry 3

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,571

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:16 UTC
Saia John G.Chief Legal Officer
Exercise / conversionCommon Stock 263 $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000062 · wk-form4_1741130180.xml · nonDerivative · entry 2

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,650

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:16 UTC
Saia John G.Chief Legal Officer
Exercise / conversionCommon Stock 5,686 $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000062 · wk-form4_1741130180.xml · nonDerivative · entry 1

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,387

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:15 UTC
Monroe Terilyn J.Chief People Officer
Exercise / conversionPerformance-Based Restricted Stock Units · Derivative 14,894 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000060 · wk-form4_1741130096.xml · derivative · entry 4

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,794

Underlying: Common Stock · 14,894 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. The remaining 67% of the shares vest over the following two years, with 33% of the shares subject to the award vesting on January 1, 2026, and 34% of the shares subject to the award vesting on January 1, 2027.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:15 UTC
Monroe Terilyn J.Chief People Officer
Tax withholdingCommon Stock 6,565 $42.55 $279,340.75
Disclosure

SEC source: 0001576280-25-000060 · wk-form4_1741130096.xml · nonDerivative · entry 2

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,257

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:15 UTC
Monroe Terilyn J.Chief People Officer
Exercise / conversionCommon Stock 14,894 $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000060 · wk-form4_1741130096.xml · nonDerivative · entry 1

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,822

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:10 UTC
EAGLE CRAIGChief Medical Officer
Exercise / conversionPerformance-Based Restricted Stock Units · Derivative 5,686 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000054 · wk-form4_1741129812.xml · derivative · entry 4

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,376

Underlying: Common Stock · 5,686 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. The remaining 67% of the shares vest over the following two years, with 33% of the shares subject to the award vesting on January 1, 2026, and 34% of the shares subject to the award vesting on January 1, 2027.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:10 UTC
EAGLE CRAIGChief Medical Officer
Tax withholdingCommon Stock 2,029 $42.55 $86,333.95
Disclosure

SEC source: 0001576280-25-000054 · wk-form4_1741129812.xml · nonDerivative · entry 2

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,613

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:10 UTC
EAGLE CRAIGChief Medical Officer
Exercise / conversionCommon Stock 5,686 $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000054 · wk-form4_1741129812.xml · nonDerivative · entry 1

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,642

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:13 UTC
Kalia KumudChief Information Officer
Exercise / conversionRestricted Stock Units · Derivative 710 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001576280-25-000058 · wk-form4_1741130014.xml · derivative · entry 6

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,421

Underlying: Common Stock · 710 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The restricted stock unit award was granted on November 2, 2021, and vested as to 25% of the shares subject to such award on September 1, 2022, the remaining 75% of the shares subject to such award vest in equal installments on each quarterly anniversary of September 1, 2022 during the three-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.